150 related articles for article (PubMed ID: 32417377)
1. Predictors of Physical Capacity 6 Months After Implantation of a Full Magnetically Levitated Left Ventricular Assist Device: An Analysis From the ELEVATE Registry.
Gustafsson F; Mirza KK; Pya Y; Shaw S; Diegeler A; Netuka I; Lavee J; Garbade J; Morshuis M; Heatley J; Saeed D; Potapov E; Schmitto JD; Zimpfer D;
J Card Fail; 2020 Jul; 26(7):580-587. PubMed ID: 32417377
[TBL] [Abstract][Full Text] [Related]
2. Clinical Implications of Respiratory Failure in Patients Receiving Durable Left Ventricular Assist Devices for End-Stage Heart Failure.
Miller PE; Caraballo C; Ravindra NG; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Ali A; Desai NR; Ahmad T
Circ Heart Fail; 2019 Nov; 12(11):e006369. PubMed ID: 31707800
[TBL] [Abstract][Full Text] [Related]
3. Usefulness of the six-minute walk test after continuous axial flow left ventricular device implantation to predict survival.
Hasin T; Topilsky Y; Kremers WK; Boilson BA; Schirger JA; Edwards BS; Clavell AL; Rodeheffer RJ; Frantz RP; Joyce L; Daly R; Stulak JM; Kushwaha SS; Park SJ; Pereira NL
Am J Cardiol; 2012 Nov; 110(9):1322-8. PubMed ID: 22819427
[TBL] [Abstract][Full Text] [Related]
4. Two-year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE Registry.
Zimpfer D; Gustafsson F; Potapov E; Pya Y; Schmitto J; Berchtold-Herz M; Morshuis M; Shaw SM; Saeed D; Lavee J; Heatley G; Gazzola C; Garbade J
Eur Heart J; 2020 Oct; 41(39):3801-3809. PubMed ID: 33107561
[TBL] [Abstract][Full Text] [Related]
5. Derivation and Validation of a Novel Right-Sided Heart Failure Model After Implantation of Continuous Flow Left Ventricular Assist Devices: The EUROMACS (European Registry for Patients with Mechanical Circulatory Support) Right-Sided Heart Failure Risk Score.
Soliman OII; Akin S; Muslem R; Boersma E; Manintveld OC; Krabatsch T; Gummert JF; de By TMMH; Bogers AJJC; Zijlstra F; Mohacsi P; Caliskan K;
Circulation; 2018 Feb; 137(9):891-906. PubMed ID: 28847897
[TBL] [Abstract][Full Text] [Related]
6. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support.
Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D
Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348
[TBL] [Abstract][Full Text] [Related]
7. Durability of left ventricular assist devices: Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) 2006 to 2011.
Holman WL; Naftel DC; Eckert CE; Kormos RL; Goldstein DJ; Kirklin JK
J Thorac Cardiovasc Surg; 2013 Aug; 146(2):437-41.e1. PubMed ID: 23490245
[TBL] [Abstract][Full Text] [Related]
8. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: Results From the ROADMAP Study.
Estep JD; Starling RC; Horstmanshof DA; Milano CA; Selzman CH; Shah KB; Loebe M; Moazami N; Long JW; Stehlik J; Kasirajan V; Haas DC; O'Connell JB; Boyle AJ; Farrar DJ; Rogers JG;
J Am Coll Cardiol; 2015 Oct; 66(16):1747-1761. PubMed ID: 26483097
[TBL] [Abstract][Full Text] [Related]
9. Six-month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry.
Gustafsson F; Shaw S; Lavee J; Saeed D; Pya Y; Krabatsch T; Schmitto J; Morshuis M; Chuang J; Damme L; Zimpfer D; Garbade J
Eur Heart J; 2018 Oct; 39(37):3454-3460. PubMed ID: 30165521
[TBL] [Abstract][Full Text] [Related]
10. Impact of Race on Clinical Outcomes After Implantation With a Fully Magnetically Levitated Left Ventricular Assist Device: An Analysis From the MOMENTUM 3 Trial.
Sheikh FH; Ravichandran AK; Goldstein DJ; Agarwal R; Ransom J; Bansal A; Kim G; Cleveland JC; Uriel N; Sheridan BC; Chomsky D; Patel SR; Dirckx N; Franke A; Mehra MR
Circ Heart Fail; 2021 Oct; 14(10):e008360. PubMed ID: 34525837
[TBL] [Abstract][Full Text] [Related]
11. Predictors of 5-Year Mortality in Patients Managed With a Magnetically Levitated Left Ventricular Assist Device.
Nayak A; Hall SA; Uriel N; Goldstein DJ; Cleveland JC; Cowger JA; Salerno CT; Naka Y; Horstmanshof D; Crandall D; Wang A; Mehra MR
J Am Coll Cardiol; 2023 Aug; 82(9):771-781. PubMed ID: 37612008
[TBL] [Abstract][Full Text] [Related]
12. Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device and Medical Management in Ambulatory Heart Failure Patients: The ROADMAP Study 2-Year Results.
Starling RC; Estep JD; Horstmanshof DA; Milano CA; Stehlik J; Shah KB; Bruckner BA; Lee S; Long JW; Selzman CH; Kasirajan V; Haas DC; Boyle AJ; Chuang J; Farrar DJ; Rogers JG;
JACC Heart Fail; 2017 Jul; 5(7):518-527. PubMed ID: 28396040
[TBL] [Abstract][Full Text] [Related]
13. Outcomes after implantation of partial-support left ventricular assist devices in inotropic-dependent patients: Do we still need full-support assist devices?
Sabashnikov A; Popov AF; Bowles CT; Mohite PN; Weymann A; Hards R; Hedger M; Wittwer T; Wippermann J; Wahlers T; Schoendube FA; Simon AR
J Thorac Cardiovasc Surg; 2014 Sep; 148(3):1115-21; discussion 1021-2. PubMed ID: 25129605
[TBL] [Abstract][Full Text] [Related]
14. Long-term evaluation of a fully magnetically levitated circulatory support device for advanced heart failure-two-year results from the HeartMate 3 CE Mark Study.
Schmitto JD; Pya Y; Zimpfer D; Krabatsch T; Garbade J; Rao V; Morshuis M; Beyersdorf F; Marasco S; Sood P; Damme L; Netuka I
Eur J Heart Fail; 2019 Jan; 21(1):90-97. PubMed ID: 30052304
[TBL] [Abstract][Full Text] [Related]
15. Effects of a fully magnetically levitated centrifugal-flow or axial-flow left ventricular assist device on von Willebrand factor: A prospective multicenter clinical trial.
Bansal A; Uriel N; Colombo PC; Narisetty K; Long JW; Bhimaraj A; Cleveland JC; Goldstein DJ; Stulak JM; Najjar SS; Lanfear DE; Adler ED; Dembitsky WP; Somo SI; Crandall DL; Chen D; Connors JM; Mehra MR
J Heart Lung Transplant; 2019 Aug; 38(8):806-816. PubMed ID: 31147187
[TBL] [Abstract][Full Text] [Related]
16. Use of left ventricular assist device (HeartMate II): a Singapore experience.
Lim CP; Sivathasan C; Tan TE; Lim CH; Kerk KL; Sim DK
Artif Organs; 2014 Jul; 38(7):543-8. PubMed ID: 24392937
[TBL] [Abstract][Full Text] [Related]
17. Causes and predictors of early mortality in patients treated with left ventricular assist device implantation in the European Registry of Mechanical Circulatory Support (EUROMACS).
Akin S; Soliman O; de By TMMH; Muslem R; Tijssen JGP; Schoenrath F; Meyns B; Gummert JF; Mohacsi P; Caliskan K;
Intensive Care Med; 2020 Jul; 46(7):1349-1360. PubMed ID: 32016536
[TBL] [Abstract][Full Text] [Related]
18. Prolonged mechanical ventilation after left ventricular assist device implantation: risk factors and clinical implications.
Papathanasiou M; Mincu RI; Lortz J; Horacek M; Koch A; Pizanis N; Kamler M; Rassaf T; Luedike P
ESC Heart Fail; 2019 Jun; 6(3):545-551. PubMed ID: 30861636
[TBL] [Abstract][Full Text] [Related]
19. Preoperative Determinants of Quality of Life and Functional Capacity Response to Left Ventricular Assist Device Therapy.
Kiernan MS; Sundareswaran KS; Pham DT; Kapur NK; Pereira NL; Strueber M; Farrar DJ; DeNofrio D; Rogers JG
J Card Fail; 2016 Oct; 22(10):797-805. PubMed ID: 26777757
[TBL] [Abstract][Full Text] [Related]
20. Pulmonary artery pulsatility index predicts right ventricular failure after left ventricular assist device implantation.
Kang G; Ha R; Banerjee D
J Heart Lung Transplant; 2016 Jan; 35(1):67-73. PubMed ID: 26212656
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
